Affordable Care Act: Up Next for Health Reform PwC’s Health Research Institute
by user
Comments
Transcript
Affordable Care Act: Up Next for Health Reform PwC’s Health Research Institute
www.pwc.com Affordable Care Act: Up Next for Health Reform PwC’s Health Research Institute February 2015 Table of Contents Section Topic Slide # I ACA timeline 3 II ACA access/coverage 5 III ACA fees and taxes 13 IV Industry shifts 18 V Regulatory/legislative issues 32 VI What remains? 36 PwC Health Research Institute 2 ACA timeline PwC Health Research Institute 3 ACA roll out hit its stride in 2014 2014 brought new coverage: – Medicaid expansion – Insurance exchange coverage – Individual mandate takes effect – Additional consumer protections pre-exist condition coverage, no annual limits, waiting periods < 90 days for coverage (Jan 2014) Insurer Provider Consumer Pharma/Life Sciences Employer Medicare payments for hospital acquired conditions reduced by 1% (Oct 2014) End of Medicare Advantage Star payment demonstration (Dec 2014) 2014 Employer mandate kicks in 2015 Medicare Part D donut hole closed (Jan 2020) 2020 High cost plan excise tax (Jan 2018) ICD-10 Enhanced wellness incentives (July 2014) Implementation (Oct 2015) Source: PwC Health Research Institute PwC Health Research Institute 4 ACA access/coverage PwC Health Research Institute 5 Most will get coverage in the first few years of ACA expansion Projected Enrollment by Year 45 42 Millions of People 40 35 30 25 20 36 Actual 2015 enrollment: 11.4M Marketplace 10.8M Medicaid* 15 10 5 7 31 12 21 11 13 2015 2016 30 30 25 25 13 14 29 29 25 24 15 16 6 0 2014 2017 2018 Exchanges 2019 Medicaid 2020 Uninsured * Marketplace enrollment as of February 15, 2015; Medicaid enrollment as of December 2014. Sources: Congressional Budget Office January 2015 Budget and Economic Outlook; Congressional Budget Office April 2014 Baseline. Numbers could change if more states expand their Medicaid programs. PwC Health Research Institute 6 The 2015 health exchange landscape 2015 national premium increase of around 5.4% Average 2015 pre-subsidy premium about $389 Among finalized states, premiums rising by about 3.7% To access HRI’s interactive premium map, visit: www.pwc.com/hri PwC Health Research Institute 7 Most 2014 exchange enrollees selected mid-level coverage • Silver plans were the most popular choice among exchange shoppers • About 85% of those who selected an exchange plan were eligible for financial assistance Platinum 5% No Assistance 15% Catastrophic 2% Gold 9% Financial Assistance 85% Bronze 20% Silver 65% Source: ASPE, “Health Insurance Marketplace: Summary Enrollment Report for the Initial Open Enrollment Report”, May 2014. PwC Health Research Institute 8 Medicaid Expansion by State* States Expanding Medicaid States Not Expanding Medicaid States to Watch WA MT ND MN OR ID WI SD NY MI WY PA IA NE NV OH UT IL IN KS VA MO OK NM DC NC AR SC AK MS TX RI CT DE MD KY TN AZ N J WV CO CA ME N V T H MA AL GA LA FL HI *As of February 25, 2015 Source: http://kff.org/health-reform/state-indicator/state-activity-around-expanding-medicaid-under-the-affordable-care-act/ PwC Health Research Institute 9 Across for-profit and non-profit hospitals, the Medicaid and self-pay mix improved in expansion states and held steady in non-expansion states % of Total Charges by Payer in Medicaid Expansion States Commercial / Other % of Total Charges by Payer in Medicaid Non-Expansion States 40.8% 39.3% 39.6% 39.3% 39.2% 38.8% 42.0% 42.1% Medicaid 15.3% 18.8% 13.6% 13.6% Self-Pay 4.7% 3.1% 4.8% 5.0% Q1 2013 Q1 2014 Q1 2013 Q1 2014 Medicare Source: HRI analysis, Center for Health Information and Data Analytics , Colorado Hospital Association, June 2014. PwC Health Research Institute 10 In Medicaid expansion states, the shifts between Medicaid and self-pay admissions were dramatic Medicaid Expansion States Community Healthy System HCA IA SIS Medicaid Non-Expansion States Tenet Healthcare Community Healthy System HCA IA SIS Tenet Healthcare 17.0% 10.0% 4.0% -28.0% Same Facility Admissions (Q1 2014 vs Q1 2013) Same Facility Admissions (Q1 2014 vs Q1 2013) 22.3% 5.9% 0.9% -1.0% -1.3% -8.1% -8.1% 2.0% -9.7% -29.0% -33.0% -40.8% Medicaid admissions Self-pay admissions Source: HRI analysis of hospital public financial data. http://www.pwc.com/us/en/health-industries/health-research-institute/assets/pwc-hri-medicaid-report-final.pdf PwC Health Research Institute 11 The future of federal exchange subsidies Halbig v. Burwell King v. Burwell DC Circuit Ct Supreme Ct to review in March 2015 Ruling: ACA does not authorize subsidies Full en banc review No subsidies Ruling: IRS has authority to apply subsidies to FFM Pruitt v. Burwell Indiana v. IRS US District Ct - OK US District Ct - IN Ruling: Subsidies, employer mandate, and individual mandate only legal under SBE Ruling: Not decided. Plaintiff argues IRS does not have authority to apply subsidies to FFM PwC Health Research Institute Subsidies 12 ACA fees and taxes PwC Health Research Institute 13 ACA fees and taxes Patient Centered Outcomes Research Institute (PCORI) fee Fee is $1 times the average number of lives covered under the plan for that plan year. Applies to policy or plan Health insurance industry fee Cadillac tax Employers taxed 40% on Assessed annually starting at health plan benefits above a threshold. and gradually increasing to $8B $14.3B in 2018; indexed to premium growth thereafter. years ending on or after 10/1/12 and before 10/1/19. 2012 2014 2011 2013 Pharmaceutical industry fee Started at $2.5B and will peak in 2018 at $4.1B. Medical device tax 2.8% excise tax expected to bring in $29.1B over 10 years. 2018 2015 Transitional reinsurance program fee Intends to collect $25B from group health plans during 2014-2016. Employer mandate Will hit employers with 100 or more employees in 2015; it will impact employers with 50 or more employees in 2016. PwC Health Research Institute 14 CMS readmissions penalties According data released by CMS on October 1, 2014: 2,610 3% 5 hospitals fined for having too many patients return within 30 days for additional treatments amount of each Medicare payment that hospitals with the highest readmission rates stand to lose— up from the 2% maximum penalty last year categories of patients for which Medicare evaluated readmissions—up from 3 categories assessed in prior years Source: Jordan Rau. “Medicare Fines 2,610 Hospitals In Third Round Of Readmission Penalties.” Kaiser Health News. October 2, 2014. http://kaiserhealthnews.org/news/medicare-readmissions-penalties-2015/ PwC Health Research Institute 15 Hospital-acquired condition penalties 1% amount that hospitals are penalized for acquired conditions 10 types of hospital acquired conditions 760 approximate # of hospitals expected to be penalized for acquired conditions Source: Jordan Rau. “Medicare Fines 2,610 Hospitals In Third Round Of Readmission Penalties.” Kaiser Health News. October 2, 2014. http://kaiserhealthnews.org/news/medicare-readmissions-penalties-2015/ PwC Health Research Institute 16 Medicare Value-Based Purchasing Program CMS initiative rewards acute-care hospitals with Medicare incentive payments for quality care Payment rates reduced to all hospitals by 1% in FY2013, 1.25% in FY2014; 1.5% in FY2015 Last year, Medicare raised payment rates for 1,231 hospitals and decreased payments to another 1,451 PwC Health Research Institute 17 Industry shifts PwC Health Research Institute 18 ACA Demonstration Programs Medicare ACO demonstrations Comprised of four programs. In 2013, generated over $370M in savings for Medicare. Duals demonstration 13 demonstrations in 12 states, 1.5M beneficiaries. Slow start – first year mark in July 2014. Medicare Advantage Stars demonstration Bonus payments for 3 or more stars end Dec 2014. Number of MA plans will decrease by 3% in 2015. PwC Health Research Institute 19 Accountable Care Organizations Medicare Shared Savings Program Pioneer ACO Model Upside/downside risk (optional) Upside/downside risk Supplementary Recently announced Cut down to 19 from 32 35 participants Only 11 of 23 organizations earned savings in year 1 (2012 or 2013) Advance payments that are repaid from future shared savings For ACOs participating in the MSSP 53 out of 220 earned performance payments of $300M in year 1 (2012 or 2013) Advance Payment ACO Model ACO Investment Model Pre-paid shared savings Geared toward rural and underserved areas Source: http://www.cms.gov/Newsroom/MediaReleaseDatabase/Fact-sheets/2014-Fact-sheets-items/2014-09-16.html PwC Health Research Institute Builds on Advance Payment Model Slide 20 20 CMS Innovation Center Innovation Model Categories Accountable Care Bundled Payments for Care Improvement Number of Participants 275 6,820 Primary Care Transformation 962 Initiatives Focused on the Medicaid and CHIP Population 204 Initiatives Focused on the Medicare-Medicaid Enrollees 19 Initiatives to Speed the Adoption of Best Practices 179 Initiatives to Accelerate the Development and Testing of New Payment and Service Delivery Models 204 Source: http://innovation.cms.gov/initiatives/index.html#views=models PwC Health Research Institute Slide 21 21 CMS expands reimbursement for telehealth services Payments to telehealth will increase by 0.8% in 2015 PwC Health Research Institute Increased payments for chronic care management and 7 new covered procedure codes 22 Physicians tell us their payment models are changing 51% 24% Of clinicians said that in 5 years, 3/4 of their total revenue will come through channels other than fee-for-service Said their practice was likely to partner or merge with a hospital, resulting in full employment by the hospital Source: HRI Clinician Survey, 2014 PwC Health Research Institute 23 Public release of Physician Sunshine data prompts scrutiny of provider/pharma relationships Pharma/med device payments to providers, per resident (2010 - 2013) MA DC FL MD SC MO PA NY CA GA CO KY ND MN ID OK MI LA WI NH DE NM IA MS HI WY $0.00 MA: $28.48 From Aug – Dec 2013, pharma and med device companies spent a total of OR: $9.80 $3.5B on hospital and physician payments WY: $1.02 $5.00 $10.00 $15.00 $20.00 $25.00 $30.00 Source: PwC analysis, ProPublica Dollars for Docs database, 2013 US Census bureau population estimates PwC Health Research Institute 24 Patient Centered Outcomes Research Institute (PCORI) $674 million awarded 400 research projects approved 42 states with research funded • Average requested project budget in 2014 was $2.3 M • Largest requested budget ($30 M) for a clinical trial on fallrelated injury prevention • Five national priorities for PCORI research • Average duration of 2.5 years for projects funded to date • Average of four projects per state (2012 – 2014) • CA has most funded projects (54), followed by MA (42) Source: PwC analysis of PCORI data. October 2014. http://www.pcori.org/researchresults?combine=&state=All&area=All&research=All&program=All&order=field_award_year&sort=desc PwC Health Research Institute 25 ACA encourages competition in the biologics market Biologic: any therapeutic product derived from a biological source Biosimilar: subsequent version of an original biologic that has the same mechanism but isn’t an identical product Spending on the top seven biologics alone represented about Competition from biosimilars would reduce drug spending by roughly of Part D spending in 2010. over 10 years. 43% $25 billion Source: Health Affairs. Health Policy Brief. Biosimilars. October 10, 2013. http://healthaffairs.org/healthpolicybriefs/brief_pdfs/healthpolicybrief_100.pdf PwC Health Research Institute 26 New entrants are aiming to disrupt the $3 trillion US health economy Source: HRI analysis and Centers for Medicare and Medicaid Services National Health Expenditures (2012) PwC Health Research Institute 27 Venture funding of digital health outpaces traditional healthcare sectors Growth in venture funding (2013 vs. 2012 and 2014 vs. 2013) 127% Legend 2013 vs. 2012 2014 vs. 2013 77% 61% 30% 29% 29% Med Device 21% 10% 9% All Venture Funding Software Digital Health Biotech -17% Source: http://www.slideshare.net/RockHealth/rock-health-2014-year-in-review-funding-1 PwC Health Research Institute 28 Regulatory/legislative issues PwC Health Research Institute 29 Medical Device Tax What it is Current Impact • 2.3% excise tax that manufacturers and • $29B over a decade importers will pay on sales of medical devices 2015 Possible Changes • Potential repeal with bipartisan opposition to the tax in Congress PwC Health Research Institute 2015 Impacts • If repealed, there is a need to determine how to recoup the revenue from the tax 30 Individual Mandate What it is • Requires that all eligible Americans have at least basic coverage starting January 1, 2014 Current Impact • If individual does not maintain coverage, fee is issued for each month individual is not covered 2015 Expected Changes • Tax penalties for individuals rise in the next year PwC Health Research Institute 2015 Impacts Tax Penalties: • 2014: $95/ adult • 2015: $325/ adult 31 Employer Mandate What it is • All businesses with over 100 FTEs must provide health insurance to full-time employees Current Impact • If employer does not offer coverage, business is penalized 2015 Expected Changes • Employers must start 2015 Impacts insuring workers by • The annual fee is 2015 (large business) $2,000 per employee if and by 2016 (small insurance isn’t offered business) (first 30 FTEs exempt) PwC Health Research Institute 32 What remains? PwC Health Research Institute 33 Even in 2015, certain elements of reform have yet to unfold Cadillac tax Medicaid expansion 2015 and beyond Federal subsidies ? King v. Burwell Employer mandate Exchange market PwC Health Research Institute 34 For more information www.pwc.com/hri PwC Health Research Institute 35